Loading clinical trials...
Loading clinical trials...
Identification of Genetic Modifying Factors in Striated Muscle Laminopathies
Conditions
Interventions
Skin Biopsy
Muscle biopsy
Locations
8
France
Centre de référence maladies neuromusculaires, Hôpital Femme Mère Enfant, CHU Lyon
Bron, Auvergne-Rhône-Alpes, France
Centre de référence maladies neuromusculaires, Institut de myologie, Hôpital Pitié-Salpêtrière
Paris, France, France
Service de Neuropédiatrie, Centre de Référence Maladies Neuromusculaires, CHU de Montpellier
Montpellier, Hérault, France
Service de Génétique médicale, CHU Rennes
Rennes, Ille-et-Vilaine, France
Laboratoire d'Explorations Fonctionnelles - Centre de Référence Maladies Neuromusculaires Rares, CHU Nantes
Nantes, Loire-Atlantique, France
Service de cardiologie & Service de Neurophysiologie - CHU de Rouen
Rouen, Normandy, France
Start Date
September 8, 2022
Primary Completion Date
September 30, 2027
Completion Date
December 30, 2027
Last Updated
March 4, 2026
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions